SCHEMBL1850964

SCHEMBL1850964

COC(OC)(c1ccccc1)c1cc2cccc(-c3cccc(C(=O)NCCN4CCCC4)c3)c2o1.COC(OC)(c1ccccc1)c1cc2cccc(-c3cccc(C(=O)O)c3)c2o1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMYD2 Q9NRG4 4/20 0.49
IKBKB O14920 1/20 0.47
ERN1 O75460 2/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PIM1 P11309 1/20 0.44
GPR52 Q9Y2T5 1/20 0.43
APP P05067 1/20 0.43
ATR Q13535 2/20 0.43
EPHX2 P34913 1/20 0.42
DRD4 P21917 1/20 0.42
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAP4K4 O95819 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1850827 0.79 SMYD2 (0.54) SMYD2ERN1GPR52DRD4CYP2C9
SCHEMBL1851120 0.76 GPR52 (0.53) SMYD2IKBKBERN1KMT2AGPR52
SCHEMBL3211200 0.75 SMYD2 (0.57) SMYD2ERN1GPR52DRD4CYP2C9
SCHEMBL774938 0.71 ERN1 (0.70) SMYD2IKBKBERN1MEN1KMT2A
SCHEMBL12203378 0.68 MEN1 (0.76) SMYD2ERN1MEN1KMT2AEPHX2
SCHEMBL1381550 0.66 ALDH1A1 (0.70) MEN1KMT2AAPPCYP2C9
SCHEMBL13060642 0.66 ERN1 (0.62) SMYD2ERN1MEN1KMT2AAPP
SCHEMBL30765155 0.65 SMN1; SMN2 (0.52) SMYD2IKBKBERN1MEN1KMT2A
SCHEMBL27260524 0.65 SMN1; SMN2 (0.52) SMYD2IKBKBERN1MEN1KMT2A
SCHEMBL4502913 0.65 CYP1A2 (0.73) MEN1KMT2AAPPCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323978-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-05-25 EP disclosed
WO-2010018874-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed